NEW YORK, June 28, 2011 /PRNewswire/ — Reportlinker.com
announces that a new market research report is available in its
catalogue:
HIV diagnostics market in India
http://www.reportlinker.com/p0463758/HIV-diagnostics-market-in-India.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology
This report covers the HIV diagnostics market in India. HIV
stands out as a highly lucrative and expanding market for
diagnostics because of the close integration of diagnostics in
day-to-day disease diagnosis, management, and drug selection. HIV
was first identified in India in 1986, in Chennai, shortly after
the Indian Council of Medical Research (ICMR) initiated
surveillance for HIV. Surveillance was later taken over by the
National AIDS Control Organization (NACO), set up under the
Ministry of Health and Family Welfare.
India is planning to scale up prevention of HIV to avoid having
to spend an increasing share of its health budget on treatment of
AIDS patients, according the World Bank and other agencies. India
has over 2.5 million AIDS patients currently. India spends about 5
percent of its $5.4 billion healthcare budget on treating AIDS
patients. India may have to spend $1.8 billion by 2020, about 7
percent of the total health expenditure, the World Bank said.
Executive Summary
Industry Overview (Global & Indian)
Biomedical research on HIV/AIDS in India
e) Tamil Nadu
f) Manipur
g) Mizoram
h) Nagaland
i) The Punjab
Market Structure and Segmentation
Types of Products
Key Players
Competition situation
Key Drivers
Key Cha
‘/>”/>
SOURCE